Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Nov;30(2):277–282.

Influence of SRBC/lymphocyte ratio on T-cell rosettes in alcoholic liver disease and inflammatory bowel disease.

M G Mutchnick, D S White, A C Dopp
PMCID: PMC1541124  PMID: 304783

Abstract

Thymus-derived (T) rosette-forming cells were enumerated in patients with alcoholic liver disease and in patients with inflammatory bowel disease using variable sheep red blood cell (SRBC)/lymphocyte ratios. SRBC/lymphocyte ratios of 60:1 and 32:1 did not reveal significant differences from controls in Crohn's disease. The percentage, but not absolute count, of T cells was significantly reduced in alcoholic hepatitis at the 60:1 ratio. Both the percentage and absolute count of T cells were reduced in alcoholic hepatitis and Crohn's disease with the 8:1 ratio. No significant reduction in T cells was seen at any ratio in patients with compensated alcoholic cirrhosis or ulcerative colitis. Use of a SRBC/lymphocyte ratio of 8:1 indentifies T cells which demonstrate an avidity for SRBC. This avidity may be related to the density of SRBC receptors on the surface of T cells and/or the affinity of these receptor sites for SRBC. Use of the 8:1 ratio may provide a more sensitive means by which to monitor changes in T-cell rosettes in patients suspected of having an altered cellular immune state.

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asquith P., Kraft S. C., Rothberg R. M. Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease. Gastroenterology. 1973 Jul;65(1):1–7. [PubMed] [Google Scholar]
  2. Berenyi M. R., Straus B., Avila L. T rosettes in alcoholic cirrhosis of the liver. JAMA. 1975 Apr 7;232(1):44–46. [PubMed] [Google Scholar]
  3. Bernstein I. M., Webster K. H., Williams R. C., Jr, Strickland R. G. Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet. 1974 Aug 31;2(7879):488–490. doi: 10.1016/s0140-6736(74)92015-7. [DOI] [PubMed] [Google Scholar]
  4. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  5. Bird A. G., Britton S. No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology. 1974 Nov;67(5):926–932. [PubMed] [Google Scholar]
  6. Chisholm R. L., Tubergen D. G. The significance of varying SRBC/lymphocyte ratio in T cell rosette formation. J Immunol. 1976 May;116(5):1397–1399. [PubMed] [Google Scholar]
  7. Diaz-Jauanen E., Strickland R. G., Williams R. C. Studies of human lymphocytes in the newborn and the aged. Am J Med. 1975 May;58(5):620–628. doi: 10.1016/0002-9343(75)90497-0. [DOI] [PubMed] [Google Scholar]
  8. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fröland S. S. Binding of sheep erythrocytes to human lymphocytes. A probable marker of T lymphocytes. Scand J Immunol. 1972;1(3):269–280. doi: 10.1111/j.1365-3083.1972.tb01818.x. [DOI] [PubMed] [Google Scholar]
  10. Husby G., Strickland R. G., Caldwell J. L., Williams R. C., Jr Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease. J Clin Invest. 1975 Nov;56(5):1198–1209. doi: 10.1172/JCI108197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mendes N. F., Tolnai M. E., Silveira N. P., Gilbertsen R. B., Metzgar R. S. Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes. J Immunol. 1973 Sep;111(3):860–867. [PubMed] [Google Scholar]
  13. Meyers S., Sacher D. B., Taub R. N., Janowitz H. D. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut. 1976 Nov;17(11):911–915. doi: 10.1136/gut.17.11.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Parent K., Barrett J., Wilson I. D. Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures. Gastroenterology. 1971 Oct;61(4):431–439. [PubMed] [Google Scholar]
  15. Sachar D. B., Taub R. N., Ramachandar K., Meyers S., Forman S. P., Douglas S. D., Janowitz H. D. T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci. 1976;278:565–573. doi: 10.1111/j.1749-6632.1976.tb47071.x. [DOI] [PubMed] [Google Scholar]
  16. Silveira N. P., Mendes N. F., Tolnai M. E. Tissue localization of two populations of human lymphocytes distinguished by membrane receptors. J Immunol. 1972 May;108(5):1456–1460. [PubMed] [Google Scholar]
  17. Smith M. A., Evans J., Steel C. M. Age-related variation in proportion of circulating T cells. Lancet. 1974 Oct 19;2(7886):922–924. doi: 10.1016/s0140-6736(74)91130-1. [DOI] [PubMed] [Google Scholar]
  18. Steel C. M., Evans J., Smith M. A. The sheep-cell rosette: test on human peripheral blood lymyphocytes: an analysis of some analysis of some variable factors in the technique. Br J Haematol. 1974 Oct;28(2):245–251. doi: 10.1111/j.1365-2141.1974.tb06659.x. [DOI] [PubMed] [Google Scholar]
  19. Strickland R. G., Korsmeyer S., Soltis R. D., Wilson I. D., Williams R. C., Jr Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology. 1974 Oct;67(4):569–577. [PubMed] [Google Scholar]
  20. Strickland R. G., Williams R. C., Jr Letter: T-cells in Crohn's disease. Gastroenterology. 1975 Jul;69(1):275–276. [PubMed] [Google Scholar]
  21. Thayer W. R., Jr, Charland C., Field C. E. The subpopulations of circulating white blood cells in inflammatory bowel disease. Gastroenterology. 1976 Sep;71(3):379–384. [PubMed] [Google Scholar]
  22. Thomas H. C., Freni M., Sanchez-Tapias J., de Villiers D., Jain S., Sherlock S. Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol. 1976 Nov;26(2):222–227. [PMC free article] [PubMed] [Google Scholar]
  23. Woody J. N., Sell K. W. Characteristics of the 'active rosette test'. I. Technical considerations of the test and comments. J Immunol Methods. 1975 Oct;8(4):331–338. doi: 10.1016/0022-1759(75)90054-x. [DOI] [PubMed] [Google Scholar]
  24. Wybran J., Carr M. C., Fudenberg H. H. The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest. 1972 Oct;51(10):2537–2543. doi: 10.1172/JCI107069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yu D. T., Clements P. J., Paulus H. E., Peter J. B., Levy J., Barnett E. V. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest. 1974 Feb;53(2):565–571. doi: 10.1172/JCI107591. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES